School of Medicine
Showing 8,451-8,460 of 13,048 Results
-
Danielle Osburg
Adm Svcs Admstr 2, Stanford Laboratory for Cell and Gene Medicine
Current Role at StanfordAt the Laboratory for Cell and Gene Medicine (LCGM), I provide administrative and operational support:
- Develop, lead and engage stakeholders in process improvement procedures and initiatives that further promote the lab culture, vision and mission.
- Implement and liaison on HR functions including recruitment, hiring, onboarding and orienting, transitions, and separations.
- Construct and ensure unit policies align with University, Department and Division initiatives, policies and guidelines.
- Manage and create communication platforms and content, sharing lab and campus wide initiatives and events; health and wellness, development offerings, affinity groups, and DEIJ.
- Generate, build and implement innovative organization systems and solutions for data management and reporting.
- Perform finance and travel transactions; STAP, P-Card, T-Card, Expense Reporting, and Procurement.
- Promote a positive culture, experience and development through the creation and coordination of in-lab training opportunities on a wide range of subjects; e.g., Wellness, Communication, Psychological Safety, Interviewing Skills -
Cherinet Desta Osebo, PhD, MSc
Postdoctoral Scholar, General Internal Medicine
Current Research and Scholarly InterestsResearch focuses on trauma systems strengthening, surgical quality improvement, and global surgery in low-resource settings. Work centers on developing and analyzing real-time trauma registries, evaluating injury patterns and outcomes, and supporting data-driven health system strengthening in sub-Saharan Africa and underserved high-income regions. Emphasis includes implementation science, capacity building, and equitable surgical care delivery.
-
Karen Osilla
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsDr. Osilla conducts health services research with a focus on supporting families impacted by substance use. Dr. Osilla has been conducting addictions research since 2006 and has been involved in clinical trials evaluating cognitive behavioral therapy, collaborative care, and motivational interviewing interventions (web and in-person) among youth, adult, military, family members, and other hard-to-reach populations.
-
Michael Ostacher
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
BioDr. Ostacher is Professor of Psychiatry and Behavioral Sciences. He is the Site Director for the Addiction Medicine Fellowship at the VA Palo Alto Health Care System, where he also serves as the Medical Director of the Pharmacology of Addiction Recovery Clinic, the Director of the Bipolar and Depression Research Program and the Co-Director of the VA/Stanford Exploratory Therapeutics Lab, the Director of Advanced Fellowship Training in Mental Illness Research and Treatment for MDs for the VISN 21 MIRECC, and the Site Director at the VA Palo Alto for Advanced Fellowship Training for Stanford. A graduate of Vanderbilt University School of Medicine, the Harvard School of Public Health, and Harvard Medical School, he completed his training at The Cambridge Health Alliance at Harvard Medical School in Adult Psychiatry, Public Psychiatry, and Geriatric Psychiatry, and is currently board certified in Psychiatry, Addiction Psychiatry, and Addiction Medicine. He is the Digital Content Editor for the journal Evidence-Based Mental Health and is on the editorial boards of Bipolar Disorders, the International Journal of Bipolar Disorders, the Journal of Clinical Psychiatry, Current Psychiatry, and Psychiatric Annals. His current research includes roles as Site Investigator for VA-BRAVE, multicenter, randomized trial comparing long-acting injectable buprenorphine to sublingual buprenorphine/naloxone, and trials of psychedelic drugs in psychiatric disorders in Veterans. With funding from NIDA, he studied, along with Jaimee Heffner, Ph.D. at the Fred Hutchinson Cancer Research Center in Seattle, smoking cessation in people with bipolar disorder using a novel online psychotherapy derived from Acceptance and Commitment Therapy. His work using a Capnometry Guided Respiratory Intervention (CGRI) for PTSD led to the FDA clearance for Freespira, a digital therapeutic, for the treatment of PTSD. His primary research interest is in large clinical trials mental health and addiction, and the implementation of evidence-based mental health practices.
